(Self-)Surveillance, Anti-Doping, and Health in Non-Elite Road Running

This article explores disciplining effects of current anti-doping surveillance systems on the health consequences of non-elites’ daily behaviors and habits. As they are left out of direct anti-doping testing and enforcement, it is tempting to argue non-elites are unaffected by anti-doping efforts focused on the elite level of their sport. However, it is because they are not subject to anti-doping surveillance systems nor forced to comply with anti-doping regulations that non-elites are implicated within the wider arena of disciplinary power that envelops both elite and non-elite athletes and anti-doping agencies (Foucault 1979). Drawing on data from 28 interviews with non-elite runners I argue these runners do conform to the rules and norms of their sport as far as they understand them, but their knowledge of banned substances is inadequate and many non-elite runners have only a superficial and sometimes incorrect understanding of doping. Many view doping and its associated health risks as a problem only of elite running, as well as a problem limited to only a handful of widely publicized performance enhancing drugs or doping methods. As a result of these misunderstandings non-elite runners are vulnerable to negative health effects of over the counter (OTC) medications and nutritional supplements, which they view as “safe” and part of normal training as a result of the current elite surveillance model of anti-doping. The recent death of a non-elite marathon runner linked to use of the unregulated energy supplement DMAA demonstrates, questionable products are used by runners who may not be fully aware of the risks of use.